218 related articles for article (PubMed ID: 34038630)
1. The COVID-19 pandemic, heart and cardiovascular diseases: What we have learned.
Piątek Z; Gać P; Poręba M
Dent Med Probl; 2021; 58(2):219-227. PubMed ID: 34038630
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 and hypertension.
Ravichandran B; Grimm D; Krüger M; Kopp S; Infanger M; Wehland M
Physiol Rep; 2021 Jun; 9(11):e14800. PubMed ID: 34121359
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
Buckley LF; Cheng JWM; Desai A
J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766
[TBL] [Abstract][Full Text] [Related]
4. Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection.
Younis JS; Abassi Z; Skorecki K
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E878-E880. PubMed ID: 32421367
[TBL] [Abstract][Full Text] [Related]
5. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?
Vitiello A; Ferrara F
Eur J Pharmacol; 2020 Sep; 883():173373. PubMed ID: 32679185
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
Dworakowska D; Grossman AB
J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633235
[TBL] [Abstract][Full Text] [Related]
7. Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic.
Gressens SB; Leftheriotis G; Dussaule JC; Flamant M; Levy BI; Vidal-Petiot E
Front Physiol; 2021; 12():624052. PubMed ID: 33692701
[TBL] [Abstract][Full Text] [Related]
8. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A
Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967
[TBL] [Abstract][Full Text] [Related]
9. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
[TBL] [Abstract][Full Text] [Related]
10. [Renin-angiotensin-aldosterone system : brief history and questions related to the COVID-19 pandemic].
Valdes-Socin H; Jouret F; Vroonen L; Scheen AJ; Lancellotti P
Rev Med Liege; 2020 Sup; 75(S1):123-129. PubMed ID: 33211434
[TBL] [Abstract][Full Text] [Related]
11. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus].
Cano F; Gajardo M; Freundlich M
Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512
[TBL] [Abstract][Full Text] [Related]
12. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
Son M; Seo J; Yang S
Hypertension; 2020 Sep; 76(3):742-749. PubMed ID: 32654557
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2/Renin-Angiotensin System: Deciphering the Clues for a Couple with Potentially Harmful Effects on Skeletal Muscle.
Gonzalez A; Orozco-Aguilar J; Achiardi O; Simon F; Cabello-Verrugio C
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114359
[TBL] [Abstract][Full Text] [Related]
14. Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.
Cappuccio FP; Siani A
Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1227-1235. PubMed ID: 32595085
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and cardiovascular disease: characteristic features in older patients.
Boureau AS; de Decker L; Berrut G; Hanon O
Geriatr Psychol Neuropsychiatr Vieil; 2020 Jun; 18(2):141-148. PubMed ID: 33064080
[TBL] [Abstract][Full Text] [Related]
16. [Cardiovascular diseases and COVID-19 : Pathophysiology, complications and treatment].
Schieffer E; Schieffer B; Hilfiker-Kleiner D
Herz; 2021 Mar; 46(2):107-114. PubMed ID: 33394058
[TBL] [Abstract][Full Text] [Related]
17. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
Gemmati D; Tisato V
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
[TBL] [Abstract][Full Text] [Related]
18. Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.
Vázquez-Cornejo E
Bol Med Hosp Infant Mex; 2020; 77(5):274-281. PubMed ID: 33064690
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
20. [ACE2 and coronavirus - a question of balance and dynamics?].
Lundström A; Sandén P
Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
